SCHEMBL17428588

SCHEMBL17428588

CC1O[C@H](C)[C@@H](C(=O)O)N1C=O

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SUCNR1 Q9BXA5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25560103 0.69 SMN1; SMN2 (0.37)
SCHEMBL19084117 0.69 SMN1; SMN2 (0.37)
SCHEMBL19083897 0.65
SCHEMBL11557901 0.63 ESR1 (0.38)
SCHEMBL5591446 0.62
SCHEMBL28795073 0.62
SCHEMBL7517135 0.62
SCHEMBL11137017 0.62
SCHEMBL1316723 0.62
SCHEMBL15700676 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3166939-B1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH INC (US) 2019-06-05 EP disclosed
WO-2016007534-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2016-01-14 WO disclosed